Terms ending in 2036
Every in-force patent on Codexis, Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,696,953 | Ketoreductase Polypeptides for the Synthesis of Chiral Compounds In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 11,236,308 | Ketoreductase Polypeptides for the Synthesis of Chiral Compounds In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 12,410,410 | Ketoreductase Polypeptides for the Synthesis of Chiral Compounds In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 10,370,648 | Engineered Imine Reductases and Methods for the Reductive Amination of Ketone and Amine Compounds In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 10,400,231 | Penicillin-G Acylases In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 10,781,436 | Penicillin-G Acylases In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 9,683,220 | Novel P450-BM3 Variants with Improved Activity In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 10,113,153 | Novel P450-BM3 Variants with Improved Activity Grace period ended Oct 30, 2026 · lapse expected · Low confidence | Codexis, Inc. | Grace period ended Oct 30, 2026 lapse expected | Low confidence | |
| US 10,450,550 | Novel P450-BM3 Variants with Improved Activity In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 10,704,030 | Novel P450-BM3 Variants with Improved Activity In force · High confidence | Codexis, Inc. | In force | High confidence | |
| 2 more term ends in 2036 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.